Mother-Infant Cohort Study in Malaysia and China
Breastmilk, Infant Gut Microbiome and the Impact on Infant Health: a Prospective Mother-Infant Cohort Study in Malaysia and China
1 other identifier
observational
200
1 country
1
Brief Summary
This mother-infant cohort study aims to determine the geographic differences in the microbial profiles in breast milk from mothers living in Malaysia and China that are potentially important determinants of infant development. It also aims to determine the impact of gut microbiome on infant health (temperament, gastrointestinal symptoms, eczema symptoms, and asthma symptoms).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2021
CompletedFirst Posted
Study publicly available on registry
June 9, 2021
CompletedStudy Start
First participant enrolled
June 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
ExpectedDecember 13, 2024
December 1, 2024
3.5 years
May 19, 2021
December 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Breastmilk microbiome
Breastmilk microbiota composition is determined by using 16S rRNA gene sequencing
from birth to 12 months
Gut microbiome
Gut microbiome diversity profile is analysed from the stool by using qPCR and sequencing approaches analysis
from birth to 12 months
Secondary Outcomes (7)
Temperament
12 months
Gastrointestinal symptoms
from birth to 12 months
Eczema symptoms
from birth to 12 months
Asthma symptoms
from birth to 12 months
Infant diet
from birth to 12 months
- +2 more secondary outcomes
Study Arms (1)
Mother and Infant
The cohort will be followed for 2 years with 8 follow-up measurement points of the infants until the age of 1 year.
Interventions
There are no interventions because it is a mother-infant cohort study
Eligibility Criteria
Pregnant women in their first trimester of pregnancy (gestational age of less than 12 weeks) who visit the selected health clinics/hospitals will be invited to participate in this study.
You may qualify if:
- Pregnant women aged between 18 and 45 years old
- Pregnant women who attend the antenatal check-up at the selected clinics/hospitals
- Pregnant women with the gestational age of less than 12 weeks
- Pregnant women who plan to attend post-natal check-ups for at least one year at the same clinic/hospital
You may not qualify if:
- Pregnant women who are diagnosed with immune deficiency
- Pregnant women who have a multiple pregnancy and preterm delivery (\<37 weeks)
- Pregnant women who plan to move out of the study area in the next one year
- Pregnant women with fetal/newborn with congenital abnormalities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Private hospital
Kajang, Selangor, 43000, Malaysia
Related Publications (5)
Gartstein MA, Rothbart MK. Studying infant temperament via the Revised Infant Behavior Questionnaire. Infant Behavior and Development. 2003;26(1):64-86. https://doi.org/10.1016/S0163-6383(02)00169-8
BACKGROUNDvan Tilburg MA, Rouster A, Silver D, Pellegrini G, Gao J, Hyman PE. Development and Validation of a Rome III Functional Gastrointestinal Disorders Questionnaire for Infants and Toddlers. J Pediatr Gastroenterol Nutr. 2016 Mar;62(3):384-6. doi: 10.1097/MPG.0000000000000962.
PMID: 26308319BACKGROUNDWilliams HC, Burney PG, Hay RJ, Archer CB, Shipley MJ, Hunter JJ, Bingham EA, Finlay AY, Pembroke AC, Graham-Brown RA, et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol. 1994 Sep;131(3):383-96. doi: 10.1111/j.1365-2133.1994.tb08530.x.
PMID: 7918015BACKGROUNDCastro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 1):1403-6. doi: 10.1164/ajrccm.162.4.9912111.
PMID: 11029352BACKGROUNDEow SY, Gan WY, Jiang T, Loh SP, Lee LJ, Chin YS, Than LTL, How KN, Thong PL, Liu Y, Zhao J, Chen L. MYBIOTA: A birth cohort on maternal and infant microbiota and its impact on infant health in Malaysia. Front Nutr. 2022 Sep 27;9:994607. doi: 10.3389/fnut.2022.994607. eCollection 2022.
PMID: 36238465DERIVED
Biospecimen
During pregnancy: maternal blood. At delivery: mother's milk. During infancy: Mother's saliva, blood, milk, feces, and urine as well as baby's saliva, blood, feces, and urine.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wan Ying Gan, PhD
Universiti Putra Malaysia
- PRINCIPAL INVESTIGATOR
Tie Min Jiang
Guilin University of Technology
- STUDY DIRECTOR
Li Jun Chen, PhD
Beijing Sanyuan Foods Co Ltd
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof. Dr.
Study Record Dates
First Submitted
May 19, 2021
First Posted
June 9, 2021
Study Start
June 3, 2022
Primary Completion
December 1, 2025
Study Completion (Estimated)
December 1, 2026
Last Updated
December 13, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share